title: Response of concomitant chronic myelogenous leukemia and chronic lymphocytic leukemia to imatinib mesylate.
authors.forename: Ju-Yoon
authors.initials: JY
authors.lastname: Yoon
authors.forename: Rajat
authors.initials: R
authors.lastname: Kumar
authors.forename: Raquel
authors.initials: R
authors.lastname: Aloyz
authors.forename: James B
authors.initials: JB
authors.lastname: Johnston
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D001549:Benzamides; D006801:Humans; D000068877:Imatinib Mesylate; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000150:complications / Q000188:drug therapy*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000150:complications / Q000188:drug therapy*; D010879:Piperazines / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate